RMD Q4 2021 Earnings — ResMed Inc. Revenue & Financial Results | Market Cap Arena

RMDResMed Inc.

$36B

Q4 2021 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$876M+13.7% YoY

Gross Profit

$491M56.0% margin

Operating Income

$242M27.6% margin

Net Income

$195M22.3% margin

EPS (Diluted)

$1.33

QoQ Revenue Growth

+14.0%

Cash Flow

Operating Cash Flow

$227M

Free Cash Flow

$196M

Stock-Based Comp.

$17M

Balance Sheet

Total Assets

$4.7B

Total Liabilities

$1.8B

Stockholders' Equity

$2.9B

Cash & Equivalents

$295M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$876M	$770M	+13.7%
Gross Profit	$491M	$449M	+9.2%
Operating Income	$242M	$223M	+8.2%
Net Income	$195M	$178M	+9.7%

Revenue Segments

Sleep And Respiratory

$780M89%

Software As Service

$96M11%

Geographic Segments

Global

$876M100%